TY - JOUR
T1 - Modulation of the fecal bile acid profile by gut microbiota in cirrhosis
AU - Kakiyama, Genta
AU - Pandak, William M.
AU - Gillevet, Patrick M.
AU - Hylemon, Phillip B.
AU - Heuman, Douglas M.
AU - Daita, Kalyani
AU - Takei, Hajime
AU - Muto, Akina
AU - Nittono, Hiroshi
AU - Ridlon, Jason M.
AU - White, Melanie B.
AU - Noble, Nicole A.
AU - Monteith, Pamela
AU - Fuchs, Michael
AU - Thacker, Leroy R.
AU - Sikaroodi, Masoumeh
AU - Bajaj, Jasmohan S.
N1 - Funding Information:
This work was supported by grant U01AT004428 from the National Center for Complementary and Alternative Medicine , grant RO1AA020203 from the National Institute on Alcohol Abuse and Alcoholism , grant RO1DK087913 from the National Institute of Diabetes and Digestive and Kidney Diseases , VA Merit Review grant BX0013280-01 , the McGuire Research Institute and partly by an investigator-initiated grant from Salix Pharmaceuticals . The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.
Funding Information:
The underlying research reported in the study was funded by the NIH Institutes of Health.
PY - 2013/5
Y1 - 2013/5
N2 - Background & Aims: The 7α-dehydroxylation of primary bile acids (BAs), chenodeoxycholic (CDCA) and cholic acid (CA) into the secondary BAs, lithocholic (LCA) and deoxycholic acid (DCA), is a key function of the gut microbiota. We aimed at studying the linkage between fecal BAs and gut microbiota in cirrhosis since this could help understand cirrhosis progression. Methods: Fecal microbiota were analyzed by culture-independent multitagged-pyrosequencing, fecal BAs using HPLC and serum BAs using LC-MS in controls, early (Child A) and advanced cirrhotics (Child B/C). A subgroup of early cirrhotics underwent BA and microbiota analysis before/after eight weeks of rifaximin. Results: Cross-sectional: 47 cirrhotics (24 advanced) and 14 controls were included. In feces, advanced cirrhotics had the lowest total, secondary, secondary/primary BA ratios, and the highest primary BAs compared to early cirrhotics and controls. Secondary fecal BAs were detectable in all controls but in a significantly lower proportion of cirrhotics (p <0.002). Serum primary BAs were higher in advanced cirrhotics compared to the rest. Cirrhotics, compared to controls, had a higher Enterobacteriaceae (potentially pathogenic) but lower Lachonospiraceae, Ruminococcaceae and Blautia (7α-dehydroxylating bacteria) abundance. CDCA was positively correlated with Enterobacteriaceae (r = 0.57, p <0.008) while Ruminococcaceae were positively correlated with DCA (r = 0.4, p <0.05). A positive correlation between Ruminococcaceae and DCA/CA (r = 0.82, p <0.012) and Blautia with LCA/CDCA (r = 0.61, p <0.03) was also seen. Prospective study: post-rifaximin, six early cirrhotics had reduction in Veillonellaceae and in secondary/primary BA ratios. Conclusions: Cirrhosis, especially advanced disease, is associated with a decreased conversion of primary to secondary fecal BAs, which is linked to abundance of key gut microbiome taxa.
AB - Background & Aims: The 7α-dehydroxylation of primary bile acids (BAs), chenodeoxycholic (CDCA) and cholic acid (CA) into the secondary BAs, lithocholic (LCA) and deoxycholic acid (DCA), is a key function of the gut microbiota. We aimed at studying the linkage between fecal BAs and gut microbiota in cirrhosis since this could help understand cirrhosis progression. Methods: Fecal microbiota were analyzed by culture-independent multitagged-pyrosequencing, fecal BAs using HPLC and serum BAs using LC-MS in controls, early (Child A) and advanced cirrhotics (Child B/C). A subgroup of early cirrhotics underwent BA and microbiota analysis before/after eight weeks of rifaximin. Results: Cross-sectional: 47 cirrhotics (24 advanced) and 14 controls were included. In feces, advanced cirrhotics had the lowest total, secondary, secondary/primary BA ratios, and the highest primary BAs compared to early cirrhotics and controls. Secondary fecal BAs were detectable in all controls but in a significantly lower proportion of cirrhotics (p <0.002). Serum primary BAs were higher in advanced cirrhotics compared to the rest. Cirrhotics, compared to controls, had a higher Enterobacteriaceae (potentially pathogenic) but lower Lachonospiraceae, Ruminococcaceae and Blautia (7α-dehydroxylating bacteria) abundance. CDCA was positively correlated with Enterobacteriaceae (r = 0.57, p <0.008) while Ruminococcaceae were positively correlated with DCA (r = 0.4, p <0.05). A positive correlation between Ruminococcaceae and DCA/CA (r = 0.82, p <0.012) and Blautia with LCA/CDCA (r = 0.61, p <0.03) was also seen. Prospective study: post-rifaximin, six early cirrhotics had reduction in Veillonellaceae and in secondary/primary BA ratios. Conclusions: Cirrhosis, especially advanced disease, is associated with a decreased conversion of primary to secondary fecal BAs, which is linked to abundance of key gut microbiome taxa.
KW - Bile acid dehydroxylation
KW - Complications of cirrhosis
KW - Dysbiosis
KW - Gut microbiota
KW - Pathogenesis
KW - Rifaximin
UR - http://www.scopus.com/inward/record.url?scp=84876294967&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=84876294967&partnerID=8YFLogxK
U2 - 10.1016/j.jhep.2013.01.003
DO - 10.1016/j.jhep.2013.01.003
M3 - Article
C2 - 23333527
AN - SCOPUS:84876294967
SN - 0168-8278
VL - 58
SP - 949
EP - 955
JO - Journal of Hepatology
JF - Journal of Hepatology
IS - 5
ER -